BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 31194614)

  • 1. Dexmedetomidine as an Option for Opioid Refractory Pain in the Hospice Setting.
    Mupamombe CT; Luczkiewicz D; Kerr C
    J Palliat Med; 2019 Nov; 22(11):1478-1481. PubMed ID: 31194614
    [No Abstract]   [Full Text] [Related]  

  • 2. A case report of dexmedetomidine used to treat intractable pain and delirium in a tertiary palliative care unit.
    Hilliard N; Brown S; Mitchinson S
    Palliat Med; 2015 Mar; 29(3):278-81. PubMed ID: 25467740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine Continuous Infusion for Refractory Cancer Pain at End of Life: A Case Report.
    Byrne JM; Mesarwi P; Edmonds KP; Atayee RS
    J Pain Palliat Care Pharmacother; 2022 Sep; 36(3):200-206. PubMed ID: 35913091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine: A Novel Strategy for Patients with Intractable Pain, Opioid-Induced Hyperalgesia, or Delirium at the End of Life.
    Hofherr ML; Abrahm JL; Rickerson E
    J Palliat Med; 2020 Nov; 23(11):1515-1517. PubMed ID: 31944877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-free perioperative analgesia for hemicolectomy in a patient with opioid-induced delirium: a case report and review of the analgesic efficacy of the alpha-2 agonist agents.
    Patil SK; Anitescu M
    Pain Pract; 2012 Nov; 12(8):656-62. PubMed ID: 22448806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine as an adjuvant analgesic for intractable cancer pain.
    Roberts SB; Wozencraft CP; Coyne PJ; Smith TJ
    J Palliat Med; 2011 Mar; 14(3):371-3. PubMed ID: 21241196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Postoperative Intravenous Patient-Controlled Analgesia with Opioid-Dexmedetomidine Combinations: An Updated Meta-Analysis with Trial Sequential Analysis of Randomized Controlled Trials.
    Peng K; Zhang J; Meng XW; Liu HY; Ji FH
    Pain Physician; 2017 Nov; 20(7):569-596. PubMed ID: 29149140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Utility of Ketamine, Lidocaine, and Mexiletine as Nonopioid Adjuvants in Complex Cancer-Associated Pain.
    Hakim RC; Edmonds KP; Atayee RS
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):15-19. PubMed ID: 29737933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three successful cases of continuous dexmedetomidine infusion for the treatment of intractable delirium associated with cancer pain].
    Komasawa N; Kimura Y; Hato A; Ikegaki J
    Masui; 2013 Dec; 62(12):1450-2. PubMed ID: 24498781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of sub-anesthetic intravenous ketamine and adjuvant dexmedetomidine when treating acute pain from CRPS.
    Nama S; Meenan DR; Fritz WT
    Pain Physician; 2010; 13(4):365-8. PubMed ID: 20648205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexmedetomidine infusion as an analgesic adjuvant during laparoscopic сholecystectomy: a randomized controlled study.
    Bielka K; Kuchyn I; Babych V; Martycshenko K; Inozemtsev O
    BMC Anesthesiol; 2018 Apr; 18(1):44. PubMed ID: 29678158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Enigma of Low-Dose Ketamine for Treatment of Opioid-Induced Hyperalgesia in the Setting of Psychosocial Suffering and Cancer-Associated Pain.
    Willeford A; Atayee RS; Winters KD; Mesarwi P
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):248-255. PubMed ID: 31125279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Dexmedetomidine for Postoperative Pain Management Following Spine Fusion Surgery in a Highly Opioid-Tolerant Patient.
    Wu J; Ku SC; Ko AL
    J Pain Palliat Care Pharmacother; 2019; 33(1-2):49-53. PubMed ID: 31465697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case Report of Subanesthetic Ketamine Bolus and Infusion for Opioid Refractory Cancer Pain.
    Forth N; Nguyen M; Grech A
    J Palliat Med; 2022 Jul; 25(7):1161-1165. PubMed ID: 35085456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breathlessness with pulmonary metastases: a multimodal approach.
    Brant JM
    J Adv Pract Oncol; 2013 Nov; 4(6):415-22. PubMed ID: 25032021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Small Dose Ketamine and Dexmedetomidine Infusion for Postoperative Analgesia in Spine Surgery--A Prospective Randomized Double-blind Placebo Controlled Study.
    Garg N; Panda NB; Gandhi KA; Bhagat H; Batra YK; Grover VK; Chhabra R
    J Neurosurg Anesthesiol; 2016 Jan; 28(1):27-31. PubMed ID: 26018671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A National Survey of Institutional Guidelines for the Use of Ketamine, Lidocaine, and Dexmedetomidine for Refractory Pain.
    Chang J; Edmonds KP; Atayee RS
    J Palliat Med; 2023 Jul; 26(7):986-991. PubMed ID: 37074348
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of dexmedetomidine and postoperative pain management in patients with adolescent idiopathic scoliosis: conclusions based on a retrospective study at a tertiary pediatric hospital.
    Jones JS; Cotugno RE; Singhal NR; Soares N; Semenova J; Nebar S; Parke EJ; Shrader MW; Hotz J
    Pediatr Crit Care Med; 2014 Jul; 15(6):e247-52. PubMed ID: 24743445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Continuous Dexmedetomidine at Home for Nearly Three Years in a Young Woman with End-Stage Cyanotic Congenital Heart Disease and Cyclic Vomiting.
    Thienprayoon R; Meyer M; Flint H; Weidner N; Hirsch R
    J Palliat Med; 2019 Oct; 22(10):1289-1292. PubMed ID: 31058565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.